Apollo launches Genomics Institute in Chennai
Apollo continues to invest in genomics technology and research for better patient care
Apollo continues to invest in genomics technology and research for better patient care
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
OriCiro's synthetic biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines
New Lexington, Massachusetts facility to provide customer education and collaboration opportunities
Nutrigenomics is the study of how genes and diet (nutrients) interact. Gene variants (genetic differences) predict how an individual’s body will respond to certain nutrients.
Cloud-native Alissa data analysis SaaS platform empowers clinical labs and researchers to scale operations with parallel analysis of genomic data
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The aim is to pursue methylation-based tools to better understand biological reactions to pharmaceuticals
At the new centre, customers get a real-time experience of the process of genetic testing and actionable plans in preventive healthcare under the expertise of certified genetic counsellors
Subscribe To Our Newsletter & Stay Updated